These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1097291)

  • 21. In vitro adsorption of possible aetiological factors of hepatic encephalopathy.
    Chamuleau RA; Schoemaker LP; Smit EM
    Int J Artif Organs; 1979 Nov; 2(6):284-8. PubMed ID: 389835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of hepatic coma with hemoperfusion through polyacrylamide hydrogel-coated charcoal.
    Gelfand MC; Knepshield JH; Cohan S; Ramirez B; Schreiner GE
    Kidney Int Suppl; 1976 Dec; (7):S239-43. PubMed ID: 1070538
    [No Abstract]   [Full Text] [Related]  

  • 23. [Plasmaperfusion through activated charcoal and amberlite XAD-7 in dogs with liver failure induced by yellow phosphorus (author's transl)].
    Horak W; Polterauer P; Renner F; Silberbauer K; Rauhs R; Mühlbacher F; Funovics J
    Z Gastroenterol; 1979 Feb; 17(2):90-8. PubMed ID: 425590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coated charcoal haemoperfusion.
    Chang TM
    Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Panel conference. Adsorbent hemoperfusion for blood purification.
    Chang TM; Winchester JF; Rosenbaum J; Saito A; Stefoni S; Shu C; Gurland HL
    Trans Am Soc Artif Intern Organs; 1980; 26():593-7. PubMed ID: 7245556
    [No Abstract]   [Full Text] [Related]  

  • 26. Haemoperfusion through activated charcoal in dogs with fulminant liver failure.
    Horák J; Horký J; Rábl M
    Digestion; 1980; 20(1):22-30. PubMed ID: 7353731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT).
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    Int J Artif Organs; 1992 Mar; 15(3):151-61. PubMed ID: 1521900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of calcium chelating agents and prostaglandin E to eliminate platelet and white blood cell losses resulting from hemoperfusion through uncoated charcoal, albumin-agarose gel, and neutral and cation exchange resins.
    Scharschmidt BF; Martin JF; Shapiro LJ; Plotz PH; Berk PD
    J Lab Clin Med; 1977 Jan; 89(1):110-9. PubMed ID: 401516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure.
    O'Grady JG; Gimson AE; O'Brien CJ; Pucknell A; Hughes RD; Williams R
    Gastroenterology; 1988 May; 94(5 Pt 1):1186-92. PubMed ID: 3280388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of possible toxins in hepatic coma including the removal of mercaptan by albumin-collodion charcoal.
    Chang TM; Lister C
    Int J Artif Organs; 1980 Mar; 3(2):108-12. PubMed ID: 7364505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmaphoresis, charcoal, and resin perfusion in experimental porcine hepatic failure.
    Alp MH; Hickman R
    Dig Dis Sci; 1986 Feb; 31(2):181-7. PubMed ID: 3943446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Hemoperfusion with activated charcoal].
    Odaka M; Hirasawa H; Tabata Y; Kobayashi H; Ohkawa M; Soeda K; Sugai T; Hayashi H; Ohtake Y; Sato H
    Nihon Rinsho; 1982; 40(4):871-7. PubMed ID: 7098057
    [No Abstract]   [Full Text] [Related]  

  • 33. Artificial liver: a baby delivered prematurely.
    Berk PD
    Gastroenterology; 1978 Apr; 74(4):789-91. PubMed ID: 631514
    [No Abstract]   [Full Text] [Related]  

  • 34. Role of infection and exchange transfusion in fulminant hepatic failure.
    de Silva DG; Fernando AJ; Devasiri IV
    Ceylon Med J; 1993 Dec; 38(4):188-90. PubMed ID: 8143336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fulminant hepatic failure and artificial liver support.
    Williams R; Ede R; Gimson AE; Hughes RD
    Indian J Gastroenterol; 1985 Jul; 4(3):177-80. PubMed ID: 3848413
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemoperfusion in chronic uremia.
    Stefoni S; Feliciangeli G; Cianciolo G; De Sanctis LB; Giardino R; Spighi M
    Boll Soc Ital Biol Sper; 1993 Nov; 69(11):675-82. PubMed ID: 8060597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Artificial liver support: requirements and approaches.
    Chang TM
    Int J Artif Organs; 1983 Jul; 6(4):178-82. PubMed ID: 6414953
    [No Abstract]   [Full Text] [Related]  

  • 38. Fulminant hepatic failure.
    Williams R
    Postgrad Med J; 1983; 59 Suppl 4():33-41. PubMed ID: 6647218
    [No Abstract]   [Full Text] [Related]  

  • 39. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New approaches in the management of fulminant hepatic failure.
    Krone CL
    Ariz Med; 1971 Apr; 28(4):284-7. PubMed ID: 4930377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.